⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZNTL News
Zentalis Pharmaceuticals, Inc. Common Stock
Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026
globenewswire.com
ZNTL
Form 8-K
sec.gov
ZNTL
The Zeigler Kalamazoo Marathon Returns Next Weekend, April 25 - 26, 2026
prnewswire.com
ZNTL
PNC
PAA
SYK
WTRG
FNB
IHRT
Form 8-K
sec.gov
ZNTL
Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
globenewswire.com
ZNTL
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZNTL
Form 8-K
sec.gov
ZNTL
Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates
globenewswire.com
ZNTL
The Zeigler Kalamazoo Marathon Returns April 25-26, 2026, Bringing Family-Friendly Fun For Everyone
prnewswire.com
BGS
ZNTL
PNC
SYK
PAR
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
globenewswire.com
ZNTL